Treatment of P16‐Negative/HPV‐Negative Oropharyngeal Squamous Cell Carcinoma: A Survey of AHNS Membership
A majority of AHNS surgeons (57.4%) believe survival for HPV-negative OPSCC is better with surgery. Most (56.5%) would treat resectable T1-T3 tumors with TORS, while the minority (26.8%) would frequently or always operate on T3-T4 tumors. There was wide variation in practice with respect to treatment intensifiication owing to remaining knowledge gaps in the field.
Authors
- Mustafa G. Bulbul (ORCID: https://orcid.org/0000-0002-1148-1896)
- Meghan T. Turner
- Neil D. Gross
- John R. de Almeida
Institutions
- West Virginia University (US)
- The University of Texas MD Anderson Cancer Center (US)
- Princess Margaret Cancer Centre (CA)
- Institute for Work & Health (CA)
Publication Details
- Journal
- Otolaryngology
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1002/ohn.70150
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00